Search

Your search keyword '"Maarouf , N."' showing total 9 results
Start Over Author "Maarouf , N." Language french
9 results on '"Maarouf , N."'

1. Valeur prédictive et sensibilité du programme de médicalisation des systèmes d’information (PMSI) par rapport aux registres des cancers : application au cancer de la thyroïde (1999-2000): Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroïd cancer (1999-2000)

Author

Carré, N., Uhry, Z., Velten, M., Trétarre, B., Schvartz, C., Molinié, F., Maarouf, N., Langlois, C., Grosclaude, P., and Colonna, M.

Published
2006
Full Text
View/download PDF

2. [Cancer incidence and survival among adolescents and young adults in France (1978-1997)]

Author

Emmanuel Desandes, Lacour B, Belot A, White-Koning M, Velten M, Tretarre B, Ea, Sauleau, Maarouf N, Av, Guizard, Delafosse P, Danzon A, Cotte C, Boutreux S, Brugières L, Centre Alexis Vautrin ( CAV ), Registre National des Tumeurs Solides de l'Enfant ( RNTSE ), Cancéropôle du Grand Est-Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Service de Biostatistique, Hospices Civils de Lyon ( HCL ), Laboratoire de Biométrie et Biologie Evolutive ( LBBE ), Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique ( Inria ) -Centre National de la Recherche Scientifique ( CNRS ), Département des maladies chroniques et traumatismes, Institut de Veille Sanitaire (INVS), FRANCIM, Réseau des registres français du cancer, Registre des cancers de la Manche, registre des cancers de la Manche, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Cancers et Populations : Facteurs de Risque, Depistage, Pratiques Diagnostiques et Therapeutiques, Université de Caen Normandie ( UNICAEN ), Normandie Université ( NU ) -Normandie Université ( NU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Département de Pédiatrie, Institut Gustave Roussy ( IGR ), Centre Alexis Vautrin (CAV), Registre National des Tumeurs Solides de l'Enfant (RNTSE), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Cancéropôle du Grand Est, Hospices Civils de Lyon (HCL), Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), CHPC - Site Louis Pasteur, Centre Hospitalier Public du Cotentin (CHPC)-Centre Hospitalier Public du Cotentin (CHPC), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Gustave Roussy (IGR), Registre des cancers de la Manche [CHPC - Site Louis Pasteur], Site Louis Pasteur [CHPC], CH Centre Hospitalier Public du Cotentin (CHPC)-CH Centre Hospitalier Public du Cotentin (CHPC), and Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (UR 3181) (CEF2P / CARCINO)

Subjects
Adult, Male, Adolescent, MESH: Registries, MESH: Survival Rate, MESH : Male, MESH : Age Distribution, [SDV.CAN]Life Sciences [q-bio]/Cancer, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, MESH: Cause of Death, Age Distribution, Cause of Death, Neoplasms, MESH : Adolescent, Humans, MESH: Neoplasms, MESH : Female, Registries, MESH: Incidence, Sex Distribution, MESH : France, MESH: Age Distribution, MESH : Sex Distribution, MESH : Cause of Death, MESH: Adolescent, MESH: Humans, Incidence, MESH: Sex Distribution, MESH : Humans, MESH: Adult, MESH : Adult, MESH : Survival Rate, Survival Analysis, MESH : Neoplasms, MESH: Male, MESH : Incidence, Survival Rate, MESH: France, MESH: Survival Analysis, Female, France, MESH : Survival Analysis, MESH: Female, MESH : Registries
Abstract

International audience; Malignancies are rare young French adults but represent the third significant cause of death in the cohort of 15-24 years of age. The aim of this study was to investigate incidence and survival rates of French adolescents and young adults with cancer. All cases of cancer occuring over a 20-year period (1978-1997) in the cohort of patients aged 15 to 24, were obtained from nine population-based registries (10 % of the French population). Basal cell carcinomas of the skin were excluded. 1161 and 1884 cases were recorded in adolescents and young adults, respectively. Overall incidence rates (IR) were 161.4/10(6) in adolescents aged 15-19 years (M/F ratio = 1.3), and 252.6/10(6) in young adults aged 20-24 years (M/F ratio : 1.2). During the 1978-97 period, the IRs appeared stable over the years, +0.4 % [CI95 % = -2.3 ; +3.1] (p = 0.79) for adolescents and +1.7 % [CI95 % = -4.0 ; +7.3] (p = 0.57) for young adults. Five-year overall survival rates were 69.1 % [CI95 % = 66.4-71.8] for adolescents and 74.5 % [CI95 % = 72.3-76.7] for young adults. The 5-year survival rate for patients 15-24 years improved from 62.0 % (CI95 % = 57.5-66.5) in 1978-82 to 80.2 % (IC95 % = 77.7-82.8) in 1993-97. Noteworthy, results in adolescents and young adults are poor compared to the ones from their younger counterparts, especially in patients with acute lymphoblastic leukemia, non-Hodgkin lymphoma, Ewing's sarcoma, osteosarcoma, rhabdomyosarcoma, and astrocytoma. Further studies are warranted to elucidate whether these differences are due to intrinsic biological properties of the tumor or to differences in clinical practices in the two populations.

Published
2007

3. Estimation de la survie des patients atteints de cancer en France. Principaux résultats issus des données des Registres du Réseau FRANCIM

Author

Bossard, N., Velten, M., Remontet, L., Belot, A., Troussard, X., Colonna, M., Maarouf, N., Bouvier, A.M., Carli, P.M., Grosclaude, P., Guizard, A.V., Danzon, Arlette, Molinié, F., Tretarre, B., Launoy, G., Raverdy, N., Halna, J.M., Schvartz, C., Arveux, P., Maynadié, M., Esteve, J., Faivre, J., Registre des cancers du Bas-Rhin, CRLCC Paul Strauss, Cancer Registry of Isère, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ) -Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ), Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)

Subjects
[SDV.CAN]Life Sciences [q-bio]/Cancer, [ SDV.CAN ] Life Sciences [q-bio]/Cancer
Published
2006

4. Le cancer du col utérin en France : incidence et survie

Author

Tretarre , B., Guizard , A.V., Remontet , L., Sauvage , M., Arveux , P., Aude , A.M., Danzon , Arlette, Molinié , F., Colonna , M., Maarouf , N., Velten , M., Raverdy , N., Esteve , J., Belot , A., Bossard , N., Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Cancer Registry of Isère, Registre des cancers du Bas-Rhin, CRLCC Paul Strauss, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), and Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC )

Subjects
[SDV.CAN]Life Sciences [q-bio]/Cancer, [ SDV.CAN ] Life Sciences [q-bio]/Cancer
Published
2006

5. Modalités de prise en charge des adolescents atteints de cancer en France de 1988 à 1997

Author

Desandes , E., Lacour , B., Sommelet , D., Danzon , Arlette, Delafosse , P., Guizard , A.V., Maarouf , N., Marr , A., Raverdy , N., Tretarre , B., Velten , M., White-Honing , M., Brugières , L., Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ) -Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ), Cancer Registry of Isère, Registre des cancers du Bas-Rhin, CRLCC Paul Strauss, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)

Subjects
[SDV.CAN]Life Sciences [q-bio]/Cancer, [ SDV.CAN ] Life Sciences [q-bio]/Cancer
Published
2006

7. [Cancer incidence and survival among adolescents and young adults in France (1978-1997)].

Author

Desandes E, Lacour B, Belot A, White-Koning M, Velten M, Tretarre B, Sauleau EA, Maarouf N, Guizard AV, Delafosse P, Danzon A, Cotte C, Boutreux S, and Brugières L

Subjects
Adolescent, Adult, Age Distribution, Cause of Death, Female, France epidemiology, Humans, Incidence, Male, Neoplasms classification, Neoplasms mortality, Registries statistics & numerical data, Sex Distribution, Survival Analysis, Survival Rate, Neoplasms epidemiology
Abstract

Malignancies are rare young French adults but represent the third significant cause of death in the cohort of 15-24 years of age. The aim of this study was to investigate incidence and survival rates of French adolescents and young adults with cancer. All cases of cancer occuring over a 20-year period (1978-1997) in the cohort of patients aged 15 to 24, were obtained from nine population-based registries (10 % of the French population). Basal cell carcinomas of the skin were excluded. 1161 and 1884 cases were recorded in adolescents and young adults, respectively. Overall incidence rates (IR) were 161.4/10(6) in adolescents aged 15-19 years (M/F ratio = 1.3), and 252.6/10(6) in young adults aged 20-24 years (M/F ratio : 1.2). During the 1978-97 period, the IRs appeared stable over the years, +0.4 % [CI95 % = -2.3 ; +3.1] (p = 0.79) for adolescents and +1.7 % [CI95 % = -4.0 ; +7.3] (p = 0.57) for young adults. Five-year overall survival rates were 69.1 % [CI95 % = 66.4-71.8] for adolescents and 74.5 % [CI95 % = 72.3-76.7] for young adults. The 5-year survival rate for patients 15-24 years improved from 62.0 % (CI95 % = 57.5-66.5) in 1978-82 to 80.2 % (IC95 % = 77.7-82.8) in 1993-97. Noteworthy, results in adolescents and young adults are poor compared to the ones from their younger counterparts, especially in patients with acute lymphoblastic leukemia, non-Hodgkin lymphoma, Ewing's sarcoma, osteosarcoma, rhabdomyosarcoma, and astrocytoma. Further studies are warranted to elucidate whether these differences are due to intrinsic biological properties of the tumor or to differences in clinical practices in the two populations.

Published
2007

8. [Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroïd cancer (1999-2000)].

Author

Carré N, Uhry Z, Velten M, Trétarre B, Schvartz C, Molinié F, Maarouf N, Langlois C, Grosclaude P, and Colonna M

Subjects
Age Factors, Aged, Algorithms, Female, France, Humans, Incidence, Logistic Models, Male, Medical Records, Middle Aged, Sensitivity and Specificity, Sex Factors, Patient Discharge, Registries, Thyroid Neoplasms epidemiology
Abstract

Background: Cancer registries have a complete recording of new cancer cases occurring among residents of a specific geographic area. In France, they cover only 13% of the population. For thyroid cancer, where incidence rate is highly variable according to the district conversely to mortality, national incidence estimates are not accurate. A nationwide database, such as hospital discharge system, could improve this estimate but its positive predictive value and sensibility should be evaluated., Methods: The positive predictive value and the sensitivity for thyroid cancer case ascertainment (ICD-10) of the national hospital discharge system in 1999 and 2000 were estimated using the cancer registries database of 10 French districts as gold standard. The linkage of the two databases required transmission of nominative information from the health facilities of the study. From the registries database, a logistic regression analysis was carried out to identify factors related to being missed by the hospital discharge system., Results: Among the 973 standardized discharge charts selected from the hospital discharge system, 866 were considered as true positive cases, and 107 as false positive. Forty five of the latter group were prevalent cases. The predictive positive value was 89% (95% confidence interval (CI): 87-91%) and did not differ according to the district (p=0,80). According to the cancer registries, 322 thyroid cancer cases diagnosed in 1999 or 2000 were missed by the hospital discharge system. Thus, the sensitivity of this latter system was 73% (70-76%) and varied significantly from 62% to 85% across districts (p<0.001) and according to the type of health facility (p<0.01)., Conclusion: Predictive positive value of the French hospital discharge system for ascertainment of thyroid cancer cases is high and stable across districts. Sensitivity is lower and varies significantly according to the type of health facility and across districts, which limits the interest of this database for a national estimate of thyroid cancer incidence rate.

Published
2006
Full Text
View/download PDF

9. [Larynx cancer in France: descriptive epidemiology and incidence estimation].

Author

Peng J, Ménégoz F, Lesec'h JM, Remontet L, Grosclaude P, Buémi A, Guizard AV, Tretarre B, Danzon A, Velten M, Maarouf N, Jougla E, Launoy G, and Dubreuil A

Subjects
Adult, Age Factors, Aged, Cohort Studies, Female, France epidemiology, Humans, Incidence, Male, Middle Aged, Sex Factors, Laryngeal Neoplasms epidemiology, Laryngeal Neoplasms mortality, Registries statistics & numerical data
Abstract

The epidemiology of cancers is known in France through mortality data provided by Inserm and morbidity data obtained by French tumor registries. The purpose of this study was to compare the incidence of laryngeal cancers in 9 French departments and to give an estimate of this incidence for the whole of France, based on this data. Incidence and mortality data were collected over the period 1978-1997. The incidence and mortality rates were estimated for each year from 1978 up to 2000. Observed incidence and mortality data in the population covered by cancer registries were modelled using age-cohort methods. An estimation of the incidence/mortality ratio was obtained from these models and applied to the mortality rates predicted from an age-cohort model for the entire French population. The estimated number of laryngeal cancers was 3,865 in males and 361 in females. There were pronounced contrasts in laryngeal cancer incidence between cancer registries. The incidence rate of laryngeal cancers were especially high in the Somme and Calvados department compared to those observed in Haut-Rhin and Tarn. The ratio incidence/mortality was 2.4 in Doubs and 1.3 in Somme. France is among the countries which have the highest rates of incidence and mortality for laryngeal cancer in Europe.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results